Self-Assessment Enhances Treatment Tracking

Screening patients who exhibit any symptoms leads to the administration of the Y-BOCS, with observed scores typically ranging from 23 to 30, indicating moderate to severe impact, particularly in individuals with comorbid anorexia. Patients often report experiencing more severe symptoms compared to clinician evaluations, highlighting the effectiveness of self-rating as a tool for monitoring treatment progress and symptom severity over time.